Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade.
Jeong S, Park E, Kim HD, Sung E, Kim H, Jeon J, Kim Y, Jung UJ, Son YG, Hong Y, Lee H, Lee S, Lim Y, Won J, Jeon M, Hwang S, Fang L, Jiang W, Wang Z, Shin EC, Park SH, Jung J.
Jeong S, et al.
J Immunother Cancer. 2021 Jul;9(7):e002428. doi: 10.1136/jitc-2021-002428.
J Immunother Cancer. 2021.
PMID: 34230109
Free PMC article.